AVNS (AVNS)
Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for AVNS yet.
Peers in Medical Devices
All in industry →ABT#1
Abbott Laboratories
$178.90B-0.81%
SYK#2
Stryker Corporation
$129.79B-0.26%
MDT#3
Medtronic plc
$112.87B-0.83%
BSX#4
Boston Scientific Corporation
$91.07B-2.05%
EW#5
Edwards Lifesciences Corporation
$45.63B-3.13%
GEHC#6
GE HealthCare Technologies Inc.
$33.27B-1.14%
PHG#7
Koninklijke Philips N.V.
$26.70B+0.29%
DXCM#8
DexCom, Inc.
$25.28B-0.18%
STE#9
STERIS plc
$21.94B-0.57%
ZBH#10
Zimmer Biomet Holdings, Inc.
$18.01B+0.02%
Recent press releases
AVNS has not issued a press release in this window.
SEC filings
All filings →AVNS has not filed an SEC document in this window.
Insider trades
All insider trades →AVNS has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
ARMISTICE CAPITAL, LLC$35.9M
3,200,000 sh+28.0%
BROWN ADVISORY INC$21.7M
1,935,802 sh-13.1%
JPMORGAN CHASE & CO$3.1M
273,718 sh-52.6%
BlackRock, Inc.$75.8M
6,750,911 sh-1.2%
270,000 sh● NEW
2,157,531 sh-8.3%
MORGAN STANLEY$12.3M
1,094,036 sh+31.4%
Royal Bank of Canada$481,000
42,880 sh-81.5%
People at AVNS
All people →Quarterly financials
Full financials →Revenue trend
03/25
$167.5M
NI $6.6M
06/25
$35.8M
NI $18.0M
09/25
$177.8M
NI -$1.4M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.03
Prior: $-1.66
Revenue sparkline